Our observations also found that oropharyngeal cancer had a better ORR of salvage therapy by univariate analysis, suggesting that the combination of cetuximab and PD-1 inhibitors might be more effective for patients with oropharyngeal cancer. Here, PDCD1 is linked to oropharynx cancer.